Circadian dysfunction in a mouse model of Parkinson's disease
Abstract
Many Parkinson's disease (PD) patients exhibit sleep disorders as part of their symptoms with evidence suggesting that REM sleep disorders may be intimately associated with this disease. Possible dysfunction in the circadian system in PD has received less attention, yet problems in circadian timing are common in neurodegenerative diseases. In the present study, we examined the expression of daily and circadian rhythms in the alpha-synuclein overexpressing (ASO) transgenic line. We found selective deficits in the expression of circadian rhythms of locomotor activity, including lower night-time activity and greater fragmentation in the wheel-running activity in this PD model. These alterations were prominent in young adult (3-4 mo) ASO mice and worsened progressively with age, consistent with prior reports of age-related loss of motor skills. The temporal distribution of sleep was also altered in the ASO mice compared to littermate controls. In the ASO mice, the peak/trough expression of the clock gene PERIOD2 was normal in the master pacemaker of the circadian system: the suprachiasmatic nucleus (SCN); however, the daytime firing rate of SCN neurons was reduced in the mutant mice. Together, this data raises the possibility that a weakening of circadian output is a core feature of PD. The reduction in magnitude of circadian output would be expected to have functional consequences throughout the body.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
SCN neuronal firing is reduced in these mice from young adulthood and progressively worsens with age, suggesting a weakened circadian pacemaker and a potential loss of dopaminergic modulation of circadian rhythms.
“SCN neuronal firing is also reduced in these mice from young adulthood and progressively worsens with age, suggesting a weakened circadian pacemaker276 and a potential loss of dopaminergic modulation of circadian rhythms via midbrain, striatal and SCN circuits277,278.”
From Rhythms of life: circadian disruption and brain disorders across the lifespan (2019) · cites this paper as [276]
Transgenic mice overexpressing α-synuclein show greater fragmentation and amplitude reduction in locomotor activity rhythms during the active phase, and these effects progress with age.
“Transgenic mice overexpressing α-synuclein (a model of PD) show greater fragmentation and amplitude reduction in locomotor activity rhythms during the active phase, and these effects progress with age276.”
From Rhythms of life: circadian disruption and brain disorders across the lifespan (2019) · cites this paper as [276]
α-synuclein transgenic mice exhibit fragmented rhythms of locomotor activity, as well as changes in firing rate in the suprachiasmatic nuclei (SCN).
“α-synuclein transgenic mice exhibit fragmented rhythms of locomotor activity, as well as changes in firing rate in the suprachiasmatic nuclei (SCN), the site of the mammalian main circadian clock (Kudo et al., 2011).”
From Circadian dysregulation in Parkinson's disease (2017) · cites this paper as Kudo et al., 2011
The citation lists haven’t been fetched yet
References 71 · Cited by 188
- Authors
- Kudo, T., Loh, D. H., Truong, D., Wu, Y., & Colwell, C. S.
- Affiliations
- University of California, Los Angeles (US)
- Corresponding author
- Colwell, Christopher S.
- Venue
- Experimental Neurology
- Publisher
- Elsevier BV
- Published
- 2011-11
- Volume
- 232
- Issue
- 1
- Pages
- 66-75
- ISSN
- 0014-4886 (ISSN-L)
- OpenAlex
- W2054425157
- Cited by
- 188
- References
- 71
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 17 · 2023: 19 · 2022: 15 · 2021: 10 · 2020: 9 · 2019: 12 · 2018: 12 · 2017: 19 · 2016: 13 · 2015: 11 · 2014: 9 · 2013: 15 · 2012: 10
- FWCI
- 5.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Experimental Neurology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Parkinson Disease Association
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
- Keywords
- Parkinson's disease, circadian rhythm, alpha-synuclein overexpression, REM sleep disorder, locomotor activity, sleep fragmentation, Period2, suprachiasmatic nucleus, clock genes, age-related motor decline, mouse model
- MeSH terms
- Aging, Animals, Cell Count, Circadian Rhythm, Disease Models, Animal, Humans, Mice, Transgenic, Motor Activity, Parkinson Disease, Suprachiasmatic Nucleus, Mice, alpha-Synuclein, Period Circadian Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review